Rehan Higgins

Sep 1, 2023 | cellandgene.com | Adam J. Crowe |Nikita Jain |Rehan Higgins |Robert Proos

By Adam Crowe, Nikita Jain, Rehan Higgins, Robert Proos, Matthew Stone and Kerstin Pohl Achieve structural elucidation and distinction of oxidative isomer impurities of lipids with EAD and the ZenoTOF 7600 system Lipid nanoparticles (LNPs) are used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system, as in the initial mRNA-based COVID vaccines.

Aug 31, 2023 | bioprocessonline.com | Adam J. Crowe |Nikita Jain |Rehan Higgins |Robert Proos

By Adam Crowe, Nikita Jain, Rehan Higgins, Robert Proos, Matthew Stone and Kerstin Pohl Achieve structural elucidation and distinction of oxidative isomer impurities of lipids with EAD and the ZenoTOF 7600 system Lipid nanoparticles (LNPs) are used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system, as in the initial mRNA-based COVID vaccines.

Aug 31, 2023 | pharmaceuticalonline.com | Adam J. Crowe |Nikita Jain |Rehan Higgins |Robert Proos

By Adam Crowe, Nikita Jain, Rehan Higgins, Robert Proos, Matthew Stone and Kerstin Pohl Achieve structural elucidation and distinction of oxidative isomer impurities of lipids with EAD and the ZenoTOF 7600 system Lipid nanoparticles (LNPs) are used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system, as in the initial mRNA-based COVID vaccines.